Dual Diagnosis
Dual diagnosis — also called co-occurring disorders or comorbid substance use and mental illness — refers to the co-occurrence of a substance use disorder and one or more other mental-health conditions. It is the rule rather than the exception in clinical SUD populations.
Overview
Dual diagnosis (also called co-occurring disorders, COD, or comorbid mental illness and substance use disorder) refers to the simultaneous presence of a substance use disorder (SUD) and one or more other mental-health conditions in the same individual. The term is widely used in clinical practice though it is not a discrete DSM-5-TR diagnosis. It encompasses any combination of substance use disorder with mood disorders, anxiety disorders, PTSD, ADHD, personality disorders, psychotic disorders, eating disorders, or other conditions.
Dual diagnosis is extraordinarily common. Approximately 50-60% of individuals with substance use disorders have at least one co-occurring mental-health condition; conversely, individuals with serious mental illness have substantially elevated rates of substance use disorders compared to general population (often 2-4x). Specific high-comorbidity combinations include alcohol use disorder + depression, opioid use disorder + PTSD, stimulant use disorder + ADHD, and any SUD + bipolar disorder.
Dual diagnosis is associated with worse outcomes than either condition alone: more severe symptoms, more relapses, more hospitalizations, higher suicide risk, more legal involvement, more housing instability, and shorter life expectancy. The conditions interact bidirectionally — substance use can precipitate, mimic, or worsen mental illness; mental illness can drive self-medication with substances.
Historically, mental-health and addiction services were segregated — patients were told to “get sober first” before mental-health treatment, or to “get mental-health stable first” before addiction treatment. Substantial evidence now supports integrated treatment, in which both conditions are addressed simultaneously by the same team. Integrated dual-diagnosis treatment produces better outcomes than sequential or parallel care across multiple outcome measures.
Effective treatment requires accurate assessment of both conditions, integrated care planning, attention to medication interactions, trauma-informed practice, peer support that addresses both conditions, and sustained engagement. Recovery is possible and is the typical outcome with appropriate care.
Signs and symptoms
- Substance use disorder symptoms — Loss of control, craving, tolerance, withdrawal, continued use despite consequences — meeting DSM-5-TR criteria for SUD.
- Mental-health condition symptoms — Concurrent symptoms of depression, anxiety, PTSD, mania, psychosis, ADHD, personality disorder, or other mental-health condition meeting diagnostic criteria.
- Symptoms that overlap or interact — Difficulty distinguishing substance-induced from primary symptoms; symptoms that worsen during use, withdrawal, or both.
- Use to manage mental-health symptoms — Pattern of using substances to manage mood, anxiety, sleep, trauma symptoms, or other distress — common across SUD populations.
- Worsening course over time — Progressive worsening of both conditions; treatment of one without the other producing only partial improvement.
- Treatment failures with single-focus care — History of multiple unsuccessful treatment attempts when only one condition was addressed at a time.
- Functional impairment — Significant impairment in work, school, relationships, finances, housing, or self-care attributable to the combined conditions.
- Suicide risk — Substantially elevated suicide risk compared to either condition alone; particularly elevated during acute periods of either condition.
- Medical complications — Higher rates of medical comorbidity (cardiovascular disease, infectious disease, liver disease, traumatic brain injury) due to combined effects.
- Social and legal consequences — Higher rates of homelessness, incarceration, family disruption, and unemployment compared to either condition alone.
Diagnostic context
Dual diagnosis is not a single DSM-5-TR diagnostic code — it is the contemporaneous presence of two or more diagnoses. Accurate assessment requires:
- Comprehensive psychiatric and substance-use history including age of onset of each condition.
- Determination of whether mental-health symptoms predate, post-date, or co-occur with substance use onset.
- Assessment of symptoms during periods of abstinence (when possible) to distinguish substance-induced from primary symptoms.
- Validated screening instruments for both substance use (AUDIT, DAST, ASSIST) and mental-health conditions (PHQ-9, GAD-7, PCL-5, MDQ, ASRS).
- Toxicology testing where appropriate.
- Medical evaluation for substance-related and primary medical conditions.
- Family and collateral information when available.
The DSM-5-TR provides framework for distinguishing primary mental disorders from substance/medication-induced disorders. Substance-induced disorders meet diagnostic criteria for the relevant condition but develop during or shortly after substance intoxication or withdrawal and resolve within a defined period after discontinuation. Primary mental disorders persist beyond substance effects and predate or post-date substance use independently.
Common dual diagnoses encountered:
- Alcohol Use Disorder + Major Depressive Disorder
- Alcohol Use Disorder + Generalized Anxiety Disorder or Social Anxiety Disorder
- Opioid Use Disorder + PTSD
- Cannabis Use Disorder + Depression or Anxiety
- Stimulant Use Disorder + ADHD
- Any SUD + Bipolar Disorder
- Any SUD + Borderline or other Cluster B Personality Disorder
- SUD + Schizophrenia or other psychotic disorder
- SUD + Eating Disorder
Causes and risk factors
The high comorbidity between substance use and mental health conditions reflects multiple interacting mechanisms:
Shared genetic vulnerability: substance use disorders and many mental-health conditions share genetic risk factors. General “p-factor” psychiatric vulnerability and specific shared vulnerabilities (e.g., between SUD and depression, ADHD, schizophrenia) are documented.
Shared neurobiological substrates: dopaminergic, serotonergic, and glutamatergic dysregulation; HPA-axis abnormalities; prefrontal-limbic regulation difficulties — all are shared across SUDs and many mental-health conditions.
Self-medication: mental-health symptoms often drive substance use as a coping strategy. Alcohol for anxiety, opioids for trauma symptoms, stimulants for ADHD or depression, cannabis for sleep, all are common patterns.
Substance-induced effects: chronic substance use can precipitate, mimic, or worsen mental-health conditions. Alcohol-induced depression, cannabis-induced psychosis, and stimulant-induced mood and anxiety symptoms are well-documented.
Common environmental risk factors: childhood adversity, trauma exposure, poverty, discrimination, social isolation, and chronic stress all elevate risk for both substance use and mental-health conditions.
Bidirectional worsening: once both conditions are present, each tends to worsen the other. Substance use disrupts treatment adherence for mental-health conditions; mental-health symptoms drive ongoing substance use; medications interact.
Treatment system fragmentation: historical separation of mental-health and addictions services has contributed to under-recognition and under-treatment of dual diagnosis. Many systems still struggle with integrated care delivery.
Typical treatments
The current standard of care is integrated treatment — both conditions addressed simultaneously by the same team or in coordinated programs. Key principles:
Integrated assessment: comprehensive evaluation of both conditions at intake, with ongoing reassessment.
Stage-matched intervention: matching intervention intensity to engagement stage (engagement, persuasion, active treatment, relapse prevention) and to severity. Motivational approaches are key in early stages.
Medications for both conditions when appropriate: antidepressants, mood stabilizers, antipsychotics, and other psychiatric medications are appropriate alongside MAT. Specific medication-substance interactions are monitored. SSRIs are generally safe in most SUDs; benzodiazepines are typically avoided except in specific contexts due to dependence and interaction risks.
Psychotherapy targeting both: evidence-based modalities adapted for dual diagnosis include integrated CBT, Seeking Safety (PTSD + SUD), DBT (BPD + SUD), and others. Trauma-focused work is important given high trauma comorbidity.
Peer support that addresses both: Double Trouble in Recovery, dual-recovery support groups, and traditional 12-step programs that accept psychiatric medication use.
Recovery support services: housing, employment, peer recovery coaches, family education and support.
Coordinated specialty care: for first-episode psychosis with substance use, coordinated specialty care models (early intervention with integrated psychiatric, substance use, and psychosocial care) produce best outcomes.
Harm reduction integration: harm-reduction approaches (naloxone, supervised consumption, drug-checking) are appropriate for individuals not engaging in abstinence-oriented treatment, regardless of mental-health status.
Family involvement: family members are often substantially affected; family education, support, and (when appropriate) family therapy are integral to comprehensive care.
Long-term, recovery-oriented framework: dual diagnosis recovery is typically multi-year. Sustained engagement, gradual stabilization, and progress in multiple life domains are realistic expectations.
When to seek help
Professional support is indicated when:
- You have a diagnosed mental-health condition and are using substances in ways that affect your recovery, medication, or symptom management.
- You have a substance use disorder and are experiencing symptoms of depression, anxiety, PTSD, mania, psychosis, or other mental-health concerns.
- Treatment for either condition alone has not produced sustained improvement.
- You have been told by clinicians that you “need to get sober first” or “get psychiatrically stable first” — integrated approaches that address both simultaneously typically produce better outcomes.
- You are using substances to manage symptoms of a mental-health condition.
- Suicide risk, self-harm urges, or thoughts of harming others are present.
- You are having difficulty accessing or coordinating care across multiple systems.
Free 24-hour crisis and addictions support: 9-8-8 (Suicide Crisis Helpline), 1-833-456-4566 (Talk Suicide Canada), 1-866-332-2322 (Alberta Health Services Addiction Helpline, 24/7), 1-866-531-2600 (ConnexOntario, 24/7), 1-855-242-3310 (Hope for Wellness Helpline, Indigenous-led, 24/7).
Frequently asked questions
Is dual diagnosis a separate diagnosis?
No. "Dual diagnosis" is a clinical descriptor for the co-occurrence of a substance use disorder and one or more other mental-health conditions. Each condition is diagnosed and coded separately under the DSM-5-TR.
Should I treat the addiction first or the mental illness first?
Neither — current best practice is integrated treatment that addresses both simultaneously. Sequential approaches ("sober first" or "psychiatrically stable first") produce worse outcomes than integrated care for most dual-diagnosis presentations.
Can I take psychiatric medication if I am in recovery from substance use?
Yes, generally. SSRIs, atypical antipsychotics, mood stabilizers, and most other psychiatric medications are appropriate in recovery from substance use disorders. Benzodiazepines, stimulants in some contexts, and certain other medications are managed carefully due to dependence or interaction risks. Many 12-step programs explicitly support medication when prescribed by a physician.
Is one condition causing the other?
The relationship is bidirectional. Mental-health conditions often drive substance use as self-medication; substance use can precipitate, mimic, or worsen mental-health conditions. Both shared underlying vulnerability and direct effects of each condition on the other contribute. Treating both simultaneously is more effective than trying to identify "the cause."
How long does dual-diagnosis treatment take?
Acute stabilization typically requires months. Sustained recovery is multi-year. Maintenance treatment (medications, therapy, peer support) may be long-term, particularly for severe presentations. Many people achieve stable recovery with sustained engagement.
My family member has both an addiction and mental illness — what can I do?
CRAFT (Community Reinforcement and Family Training) and similar evidence-based family interventions support family members of people with substance use disorders. Family support groups (Al-Anon, Nar-Anon, NAMI Family Support Groups, family peer support) provide community. Independent therapy for family members is often essential. Family education programs are increasingly available through dual-diagnosis treatment programs.
References
- Substance Abuse and Mental Health Services Administration. (2020). Substance Use Disorder Treatment for People With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42.
- Drake, R. E., et al. (2008). A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 31(4), 360–374.
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). APA.
- Mueser, K. T., Noordsy, D. L., Drake, R. E., & Fox, L. (2003). Integrated Treatment for Dual Disorders: A Guide to Effective Practice. Guilford Press.
- Najavits, L. M. (2002). Seeking Safety: A Treatment Manual for PTSD and Substance Abuse. Guilford Press.
Find the pattern behind what's been feeling hard
A few simple questions to help surface the concerns that may fit best.
Find Your PatternFind a Therapist by City
Browse therapy availability by city to see local and virtual options, explore services, and connect with a clinician who can serve your area.
Find a Therapist by Province
Browse therapy options by province to see which clinicians are available to work with clients in your region.
Trusted by Leading Psychology & Mental Health Organizations Across Canada
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Trusted By Alberta’s Leading Psychology & Mental Health Organizations
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.
Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.
